Switch to:
GuruFocus has detected 4 Warning Signs with Cryo-Cell International Inc $CCEL.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cryo-Cell International Inc (OTCPK:CCEL)
Research & Development
$0.06 Mil (TTM As of Feb. 2017)

This is the expense the company spent on research and development. Cryo-Cell International Inc's research and development for the three months ended in Feb. 2017 was $0.02 Mil. Its research and development for the trailing twelve months (TTM) ended in Feb. 2017 was $0.06 Mil.


Definition

This is the expense the company spent on research and development.

Cryo-Cell International Inc Research & Development for the trailing twelve months (TTM) ended in Feb. 2017 was 0.012 (May. 2016 ) + 0.014 (Aug. 2016 ) + 0.019 (Nov. 2016 ) + 0.015 (Feb. 2017 ) = $0.06 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cryo-Cell International Inc Annual Data

Nov07Nov08Nov09Nov10Nov11Nov12Nov13Nov14Nov15Nov16
Research & Development 0.550.190.100.130.180.110.040.060.050.05

Cryo-Cell International Inc Quarterly Data

Nov14Feb15May15Aug15Nov15Feb16May16Aug16Nov16Feb17
Research & Development 0.010.010.010.010.010.010.010.010.020.02
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK